GHRL and attention deficit-hyperactivity disorder: Gürbüz et al. (2016) observed significant decreases in body weight z-score, BMI, and BMI z-score, alongside increased leptin and decreased ghrelin levels, in children and adolescents with ADHD after 3 months of extended-release OROS methylphenidate treatment.